Retweets, Likes of Tweets by @AVIVA1950 @pharma_BI on May 8, 2018 for 12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott, Cambridge
@USAIC #USAIC2018
Curator: Aviva Lev- Ari, PhD, RN
Re-Tweets of MY TWEETS: via
@pharma_BI
@AVIVA1950
for 12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott Cambridge
@USAIC
#USAIC2018
Stephen J Williams Retweeted your Tweet
Aviva Lev-Ari @AVIVA1950
Dr. David Goldstein, Director, Institute for Genomic Medicine, Columbia University Medical Center Clinical Trials in AD are very expensive collection of Data of AD populations for subgroups of Patients: Epilepsy vs AD Heterogeneity of AD @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Aviva Lev-Ari @AVIVA1950
SYNOPSIS @USAIC #USAIC2018 by @pharma_BI @AVIVA1950 for 12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott Cambridge https://pharmaceuticalintelligence.com/2018/01/18/12th-annual-us-india-biopharma-healthcare-summit-may-8-2018-marriott-cambridge/ … via @Pharma_BI
Aviva Lev-Ari @AVIVA1950
Dr. Meeta Chatterjee, Head, Business Strategy & Operations, Business Development & Licensing, Merck Research Labs Biomarkers as surugate for Outcomes reduce cost of drug development very expensive @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Aviva Lev-Ari @AVIVA1950
@SteliosPapadopoulos @Biogen Investors in Public Companies 80s Biotech @biogen @Genzyme @Amgen @Genetech in 90s @MedicinalChemistry Disappointment 2000-2010, Excitement 2015 on investment is generously @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Aviva Lev-Ari @AVIVA1950
Academic Young entrepreneurs How the split of the rewards determined between the Academic institutions and the Investor? @AnsbertGadicke in China and in The US that definition of rewards is very different. @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Aviva Lev-Ari @AVIVA1950
BioParma Innovation + @AffordablePrice Measurable #MedicalVALUE Drivers of Positive return on R&D: #Payers, #Genomics, #smartmoney, #sophisticatedconsumers of messy #data identify UNDIAGNOZED Patients @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Aviva Lev-Ari @AVIVA1950
Academic Young entrepreneurs How the split of the rewards determined between the Academic institutions and the Investor? #AnsbertGadicke in CHina and in The US that definition of rewards is very different. @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Aviva Lev-Ari @AVIVA1950
@BruceChabner @MGH@HMS @DanaFarber they CREATED the Diagnostics Industry via Genomics pioneering testing and linking to therapy Most of the World does not have ACCESS to #Diagnostics for #PatientSelection @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Aviva Lev-Ari @AVIVA1950
#PhilipRowlands, Head of the Oncology Therapeutic Area Unit, @Takeda Pharmaceuticals Oncology got MOST investment by Pharma assays challenge of Resistence, how prioritization of combination therapy @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Aviva Lev-Ari @AVIVA1950
Panel on Investment: @AnsbertGadicke, Founder & Managing Director @MPM Capital @SteliosPapadopoulos, Chairman @Biogen @TsutomuUne, Senior Corporate Advisor, @GCACorporation Moderator: @WilliamChin, Professor of Medicine, Emeritus @HMS @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Database Integration Retweeted your Tweet
Aviva Lev-Ari @AVIVA1950
@ShahramEbadollahi #IBM @Watson #blockchain #AI is foundational @ColinHill, Chairman & CEO, @GNSHealthcare believes in digitization in Healthcare #BigData used for #repurposing #drugdevelopment and new #drugcombinations development @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Albert Boxler and Logan Stewart followed you
Jerome Gels liked your Tweet
Aviva Lev-Ari @AVIVA1950
BioParma Innovation + @AffordablePrice Measurable #MedicalVALUE Drivers of Positive return on R&D: #Payers, #Genomics, #smartmoney, #sophisticatedconsumers of messy #data identify UNDIAGNOZED Patients @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Eliances Community liked your Tweet
@SteliosPapadopoulos @Biogen Investors in Public Companies 80s Biotech @biogen @Genzyme @Amgen @Genetech in 90s @MedicianlChemistry Disappointment 2000-2010, Excitement 2015 on investment is generously @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Zos liked your reply
Aviva Lev-Ari @AVIVA1950
@StevenPaul CEO @VoyagerTherapeutics #Bipolar #Schizophrenia much development of techniques and methodologies but these diseases are not well known, yet new cycle of development on its way @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Cris De Luca liked your Tweet
Aviva Lev-Ari @AVIVA1950
@MathaiMammen @JnJ Emphasize Disease vs Organizational assignment of science space is crucial hiring people with conviction @MichaelEhlers @Biogen BEST people for Science bench @AndrewPlump @Takeda all efforts on PARTNERSHIPS and culture @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Genomics Edtech Retweeted your Tweet
Aviva Lev-Ari @AVIVA1950
BioParma Innovation + @AffordablePrice Measurable #MedicalVALUE Drivers of Positive return on R&D: #Payers, #Genomics, #smartmoney, #sophisticatedconsumers of messy #data identify UNDIAGNOZED Patients @USAIC #USAIC2018 @pharma_BI @AVIVA1950
C The Crypto Fox, Bharat Ghankutkar and GNS Healthcare liked your Tweet
Aviva Lev-Ari @AVIVA1950
@ShahramEbadollahi #IBM @Watson #blockchain #AI is foundational @ColinHill, Chairman & CEO, @GNSHealthcare believes in digitization in Healthcare #BigData used for #repurposing #drugdevelopment and new #drugcombinations development @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Cash For Your Warhol liked your Tweet
Aviva Lev-Ari @AVIVA1950
#VijayChandru, Chairman, @StrandLifeSciences Cost compression Data scientists cooperation on Health IT US and India model @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Crypto Goddess 🙂 liked your Tweet
Aviva Lev-Ari @AVIVA1950
#Blockchain platform decision medicine drugs, #AI leverage data already existing find new dedication from data collected in the past @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Sarah Morgan liked your reply
Aviva Lev-Ari @AVIVA1950
@JonathanEpstein @UPenn collaboration with 200 Novartis employees on site at the Medical School Clinical Trial and Manufacturing Cell-based therapies OUTSTANDING Clinicians kept the patient alive during the drug development immunetherapy @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Nate Agapi and Justin Farrell followed you
Rubeena Qurashi liked your Tweet
Aviva Lev-Ari @AVIVA1950
Discovery to Commercialization – Data is Fragmented across institutions Diabetes Patients had higher risk for CVD in comparison to Obese Patient non-Diabetes – that data to confirm and monitor was not integrated. @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Cash For Your Warhol liked your Tweet
Aviva Lev-Ari @AVIVA1950
#NeuroDiseases Panelists: @AlfredSandrock @Biogen @DavidGoldstein @Columbia @MaurizioFava @HMS @MeetaChatterjee @Merck @StevenPaul @Voyager @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Georgia Mitsi and USAIC Retweeted your reply
Aviva Lev-Ari @AVIVA1950
@JonathanEpstein @UPenn collaboration with 200 Novartis employees on site at the Medical School Clinical Trial and Manufacturing Cell-based therapies OUTSTANDING Clinicians kept the patient alive during the drug development immunetherapy @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Georgia Mitsi liked your reply
Aviva Lev-Ari @AVIVA1950
@JonathanEpstein @UPenn collaboration with 200 Novartis employees on site at the Medical School Clinical Trial and Manufacturing Cell-based therapies OUTSTANDING Clinicians kept the patient alive during the drug development immunetherapy @USAIC #USAIC2018 @pharma_BI @AVIVA1950
MY TWEETS: via
@pharma_BI
@AVIVA1950
at for 12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott Cambridge
@USAIC
#USAIC201
2 replies 32 retweets 49 likes
More
SYNOPSIS @USAIC #USAIC2018 by @pharma_BI @AVIVA1950 for 12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott Cambridge https://pharmaceuticalintelligence.com/2018/01/18/12th-annual-us-india-biopharma-healthcare-summit-may-8-2018-marriott-cambridge/ … via @Pharma_BI
More
@AndrewPlump Chief Medical and Scientific Officer @Takeda Role of #AcademicInstitutions in Innovation and R&D?
More
@VijayChandru, Chairman, @StrandLifeSciences Cost compression Data scientists cooperation on Health IT US and India model @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@ShahramEbadollahi @IBMWatson Access of Patient data, clinical Trial data, medical record data Tested on a Bitcoin platform using encryption as a Trusted distributed data architecture system @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@ShahramEbadollahi @IBMWatson #AI #Bitcoin is a platform for integration of all the records for Watson platform transaction – establish TRUST based on the cryptography of the system consent to share data FDA and CDC as Partner to TEST data @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Technology Platforms @ChrisBenko, Co-Founder & CEO @KoneksaHealth @ColinHill CEO @GNSHealthcare @PeterMueller, Chairman, @BioXcelTherapeutics @ShahramEbadollahi @IBM Watson Health Group, IBM @VijayChandru, Chairman @StrandLifeSciences @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@SusanHockfield ex-President @MIT Thesis is a source of ideas @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@GeorgeDaley Dean @HMS PhD Program Faculties spend Sabbaticals in Industry BIOLOGY IS ADVANCING FAST NEW PROGRAMS FOR HTERAPIES @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Like
View Tweet activity
More
@SusanHockfield ex-President @MIT the INTELLIGENT WEST #AI # Radiology interpretation @ReginaBarzilay revising curriculum to reinvent the FIELD basket of problems industry people on Campus searching @MIT Basket of experiment & ideas @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@GeorgeDaley Dean @HMS Tools penetration systems going back and forth between models Interdisciplinary institutes, @Harvard Centers for research Projects do not get advanced enough to interest VCs 100 faculties mroject not advanced enough @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@SusanHockfield ex-President @MIT Foundations MIT faculties go back and forth to Industry Research in Educ Institution, purpose of Univ different that Top-DOwn Org producing @MIT #engineering and #BiologicalSciences are placed together @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@GeorgeDaley Dean @HMS Science happens faster, ecosystem In 15 yrs different system rethink new ways 35 years of incubation accelerate process invest in regulatory change the Game to eb cheaper better faster invest in new Initiative @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Fireside Chat: @GeorgeDaley Dean @HMS @SusanHockfield President Emerita & Professor of Neuroscience @MIT Moderator: @AndrewPlump Chief Medical and Scientific Officer @Takeda @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Academic Young entrepreneurs How the split of the rewards determined between the Academic institutions and the Investor? @AnsbertGadicke in CHina and in The US that definition of rewards is very different. @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@AnsbertGadicke, Founder & Managing Director, MPM Capital Invest in combinations therapy in one vial several times cheaper than each agent alone @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@SteliosPapadopoulos, Chairman @Biogen Studies on #Prevention – CVD Endpoint right drug to get to endpoint by clinical trials #Vaccines: validate science that it can be done @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@WilliamChin, Professor of Medicine, Emeritus, Harvard Medical School Notion A1C took decades to develop @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@TsutomuUne, Senior Corporate Advisor @GCA Corporation Need to care for ELderly population should direct the investment – we started with therapy then prevention @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@AnsbertGadicke, Founder & Managing Director @MPM Capital Academic founders of start ups – innovations from Academia @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@AnsbertGadicke, Founder & Managing Director @MPMCapital Investment of private funds $50Million in a start up on average stay away from Capital market @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@SteliosPapadopoulos, Chairman @Biogen New compounds is the name of the game for pipeline of drugs @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@TsutomuUne, Senior Corporate Advisor, @GCACorporation invest in buying the opportunity to participate @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@AnsbertGadicke @MPMCapital New Directions: Own money for IMPACT module invest in young investigators investment in Underdeveloped countries to offer access to drugs @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@SteliosPapadopoulos @Biogen Investors in Public Companies 80s Biotech @biogen @Genzyme @Amgen @Genetech in 90s @MedicianlChemistry Disappointment 2000-2010, Excitement 2015 on investment is generously @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Panel on Investment: @AnsbertGadicke, Founder & Managing Director @MPM Capital @SteliosPapadopoulos, Chairman @Biogen @TsutomuUne, Senior Corporate Advisor, @GCACorporation Moderator: @WilliamChin, Professor of Medicine, Emeritus @HMS @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Translate Tweet
More
@VictoriaRichon, President & CEO @Ribon Therapeutics @KurtStoeckli @Glen Pharmaceuticals – EARLY detection continues to be the calprit of Therapy Outcome @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@VictoriaRichon, President & CEO, @Ribon Therapeutics Biomarker development for use in assignment of Patients to Clinical Trials @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@BruceChabner @MGH@HMS @DanaFarber they CREATED the Diagnostics Industry via Genomics pioneering testing and linking to therapy Most of the World does not have ACCESS to #Diagnostics for #PatientSelection @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Reimbursement for Diagnostics @PhilipRowlands @Takeda Oncology is very competitive next generation is combination therapy – which one to own @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@RakeshJain @MGH @HMS Biomarkers needs for the micro-environment of the Tumors @KurtStoeckli #PrecisionTherapy will be key for cost efficiencies @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@BruceChabner @MGH @HMS – DRUG-Based Biomarkers – circulating DNA, Exosomes moving directly to Clinical Trials @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@PhilipRowlands, Head of the Oncology Therapeutic Area Unit, @Takeda Pharmaceuticals Oncology got MOST investment by Pharma assays challenge of Resistence, how prioritization of combination therapy @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@RakeshJain, #TumorBiology, @MGH Cancer Center @HMS Immuno supression caused by Hypoxia, improve oxigenation buy prescription of antihypertension drugs, stinulate the innume system checkpoint blockers @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#Oncology Panelists: Moderator: @RajuKucherlapati @HMS @BruceChabner @MGH @HMS @KurtStoeckli @Glenmark @PhilipRowlands @Takeda @VictoriaRichon @RibonTherapeutics @RakeshJain @MGH @HMS @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Translate Tweet
More
@MathaiMammen @JnJ Emphasize Disease vs Organizational assignment of science space is crucial hiring people with conviction @MichaelEhlers @Biogen BEST people for Science bench @AndrewPlump @Takeda all efforts on PARTNERSHIPS and culture @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@MichaelEhlers, Head of Research & Development, Biogen moved from Pfizer to Biogen HUMAN BIOLOGY across the board scientific clinical judgement scientists that scrutinize data and are skeptical are reluctant to be Sales @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@AndrewPlump, Chief Medical and Scientific Officer @Takeda Pharmaceuticals out of 12 drugs introduced in decade 4 got to market all were acquisitions transformation 2013 restructuring lab updates new pipeline – stabilize stage @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Drug Discovery: @AndrewPlump, Chief Medical and Scientific Officer, @Takeda @MathaiMammen, Global Head of R&D, @Janssen Pharmaceutical- JnJ @MichaelEhlers, Head of Research & Development @Biogen Moderator: @Martin Mackay CEO @Rallybio @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
BioParma Innovation + @AffordablePrice Measurable #MedicalVALUE Drivers of Positive return on R&D: #Payers, #Genomics, #smartmoney, #sophisticatedconsumers of messy #data identify UNDIAGNOZED Patients @USAIC #USAIC2018 @pharma_BI @AVIVA1950
0 replies 2 retweets1 like
More
BioPharma: An Extraordinary BioPharma Disruption @AjayDhankhar, Senior Partner, @McKinsey @SastryChilukuri @McKinsey Big-4 Disruptions: #Aging #Urbanization #Globalization #TechnoAcceleration: #IT #Buildingblocks #Robotics #NewEnergy @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Translate Tweet
More
@ShahramEbadollahi #IBM @Watson #blockchain #AI is foundational @ColinHill, Chairman & CEO, @GNSHealthcare believes in digitization in Healthcare #BigData used for #repurposing #drugdevelopment and new #drugcombinations development @USAIC #USAIC2018 @pharma_BI @AVIVA1950
0 replies1 retweet3 likes
More
#Blockchain platform decision medicine drugs, #AI leverage data already existing find new dedication from data collected in the past @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#VijayChandru, Chairman, @StrandLifeSciences Cost compression Data scientists cooperation on Health IT US and India model @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#ShahramEbadollahi @IBMWatson Access of Patient data, clinical Trial data, medical record data Tested on a Bitcoin platform using encryption as a Trusted distributed data architecture system @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#ShahramEbadollahi @IBMWatson #AI #Bitcoin is a platform for integration of all the records for Watson platform transaction – establish TRUST based on the cryptography of the system consent to share data FDA and CDC as Partner to TEST data @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Technology Platforms #ChrisBenko, Co-Founder & CEO @KoneksaHealth #ColinHill CEO @GNSHealthcare #PeterMueller, Chairman, @BioXcelTherapeutics #ShahramEbadollahi @IBM Watson Health Group, IBM #VijayChandru, Chairman @StrandLifeSciences @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Academic Young entrepreneurs How the split of the rewards determined between the Academic institutions and the Investor? #AnsbertGadicke in CHina and in The US that definition of rewards is very different. @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#SteliosPapadopoulos focus on DISTRUCTIVE treatment price control, regulation will impact investment @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#AnsbertGadicke, Founder & Managing Director, MPM Capital Invest in combinations therapy in one vial several times cheaper than each agent alone @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#SteliosPapadopoulos, Chairman @Biogen Studies on #Prevention – CVD Endpoint right drug to get to endpoint by clinical trials #Vaccines: validate science that it can be done @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#William Chin, Professor of Medicine, Emeritus, Harvard Medical School Notion A1C took decades to develop @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#TsutomuUne, Senior Corporate Advisor @GCA Corporation Need to care for ELderly population should direct the investment – we started with therapy then prevention @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#AnsbertGadicke, Founder & Managing Director @MPM Capital Academic founders of start ups – innovations from Academia @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#AnsbertGadicke, Founder & Managing Director @MPMCapital Investment of private funds $50Million in a start up on average stay away from Capital market @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#SteliosPapadopoulos, Chairman @Biogen New compounds is the name of the game for pipeline of drugs @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#TsutomuUne, Senior Corporate Advisor, @GCACorporation invest in buying the opportunity to participate @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#AnsbertGadicke @MPMCapital New DIrections: Own money for IMPACT module invest in young investigators investment in Underdeveloped countries to offer access to drugs @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#SteliosPapadopoulos @Biogen Investors in Public Companies 80s Biotech @biogen @Genzyme @Amgen @Genetech in 90s @MedicianlChemistry Disappointment 2000-2010, Excitement 2015 on investment is generousely @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Panel on Investment: @AnsbertGadicke, Founder & Managing Director @MPM Capital #SteliosPapadopoulos, Chairman @Biogen @TsutomuUne, Senior Corporate Advisor, @GCACorporation Moderator: @WilliamChin, Professor of Medicine, Emeritus @HMS @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@AndrewPlump, Chief Medical & Scientific Officer, @Takeda Pharmaceuticals In the Past Cancer was a death sentence NOT any more, we see therapy and cure in Oncology @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#VictoriaRichon, President & CEO @Ribon Therapeutics #KurtStoeckli @Glen Pharmaceuticals – EARLY detection continues to be the calprit of Therapy Outcome @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@RakeshJain, @MGH @HMS IF 85% of blood vessels in tumor are collapsed (hypoxia) how do you deliver drugs to the tumor?? @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#Diagnostics is not a viable model for #Investors unless the reimbursement will change the process for diagnostics approval is like of drugs @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#VictoriaRichon, President & CEO, @Ribon Therapeutics Biomarker development for use in assignment of Patients to Clinical Trials @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#BruceChabner @MGH@HMS @DanaFarber they CREATED the Diagnostics Industry via Genomics pioneering testing and linking to therapy Most of the World does not have ACCESS to #diagnostics #Diagnostics for #PatientSelection @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Reimbursement for Diagnostics #PhilipRowlands @Takeda Oncology is very competitive next generation is combination therapy – which one to own @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#RakeshJain @MGH @HMS Biomarkers needs for the micro-environment of the Tumors #KurtStoeckli #PrecisionTherapy willl be key for cost efficiencies @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Dr. Kurt Stoeckli, President and Chief Scientific Officer, Glenmark Pharmaceuticals – cost effectiveness by clinical trial design and biomarkers @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#BruceChabner @MGH @HMS – DRUG-Based Biomarkers – circulating DNA, Exosomes moving directly to Clinical Trials @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#PhilipRowlands, Head of the Oncology Therapeutic Area Unit, @Takeda Pharmaceuticals Oncology got MOST investment by Pharma assays challenge of Resistence, how prioritization of combination therapy @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@KurtStoeckli, President and Chief Scientific Officer, Glenmark Pharmaceuticals Translational Experiment on going origin of the cells, microenvironment, immuno science models @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@VictoriaRichon, President & CEO @RibonTherapeutics DO we have the bIomarkers, do we ahve the right Trial, How to bring new therapies – agree Biomarkers are kEY @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Dr. Kurt Stoeckli, President and Chief Scientific Officer, Glenmark Pharmaceuticals Testing the right combination therapy is critical @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Dr. Bruce Chabner, Director of Clinical Research, Mass General Hospital Cancer Center/Harvard Medical School told historic milestory in Oncology Therapy @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#RakeshJain, #TumorBiology, @MGH Cancer Center @HMS Immuno supression caused by Hypoxia, improve oxigenation buy prescription of antihypertension drugs, stinulate the innume system checkpoint blockers @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#Oncology Panelists: Moderator: #RajuKucherlapati @HMS #BruceChabner @MGH @HMS #KurtStoeckli @Glenmark #PhilipRowlands @Takeda #VictoriaRichon @RibonTherapeutics #RakeshJain @MGH @HMS @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Translate Tweet
More
@AlfredSandrock #CMO @Biogen Sensors better than neuro-cognitive testing and assessment of cognition @MaurizioFava @HMS The ALL OF US One Million Volunteer is very promising for research @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@DavidGoldstein, Director, Institute for Genomic Medicine, @Columbia University Medical Center Accelerate getting Knowledge of the disease, CF biology was known in AD combination of Amyloid in MRI Imaging and Genomics in combination @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@MaurizioFava @HMS Leverage Big Data very important in Clinical Trial Design, Biomarkers Using #ML on Data we are close best minds are applied to #AI Universities must become user-friendly to Industry for Clinical Trials @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@StevenPaul @VoyagerTherapeutics SLOWING the disease by 6 years save 50% of the dying from disease @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Moderator: @SteveUden, Co-Founder, @Rallybio Identify Early disease, @StevenPaul @VoyagerTherapeutics Biomarkers: if Amyloid at age 40 – progression to AD predicted, TAU predicts progression of AD @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Dr. David Goldstein, Director, Institute for Genomic Medicine, Columbia University Medical Center Clinical Trials in AD are very expensive collection of Data of AD populations for subgroups of Patients: Epilepsy vs AD Heterogeneity of AD @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Dr. Meeta Chatterjee, Head, Business Strategy & Operations, Business Development & Licensing, Merck Research Labs Biomarkers as surugate for Outcomes reduce cost of drug development very expensive @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@StevenPaul, President and Chief Executive Officer, Voyager Therapeutics CNS is not to be compare with antiCHolesterol DIsease, Ameloid is necessary not sufficient @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@MeetaChatterjee, Head, Business Strategy & Operations, Business Development & Licensing, @Merck In ImmunoOncology great success BUT in Dimentia and Alzheimer’s Disease NO success to compare @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@StevenPaul CEO @VoyagerTherapeutics #Bipolar #Schizophrenia much development of techniques and methodologies but these diseases are not well known, yet new cycle of development on its way @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@DavidGoldstein #GenomicMedicine @Columbia CNS diseases: ALS, Epilepsy NOT only and NOT primarily Genomics Focus on Disease but pathways, proteins @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Early Clinical Trials in #MultitpleSclerosis Breakthrough is using MRI for disease progression prediction @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
#NeuroDiseases Panelists: @AlfredSandrock @Biogen @DavidGoldstein @Columbia @MaurizioFava @HMS @MeetaChatterjee @Merck @StevenPaul @Voyager @USAIC #USAIC2018 @pharma_BI @AVIVA1950
Translate Tweet
More
@JonathanEpstein Students are in need for internships with Industry and develop entrepreneurships @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
DIscovery to Commercialization – Data is Fragmented across institutions Diabetes Patients had higher risk for CVD in comparison to Obese Patient non-Diabetes – that data to confirm and monitor was not integrated. @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@ChasBountra @Oxford Accessing in the UK across all Academia opening resources: Goventment funds, Takeda helps in resources needed for integration of sources WHile in Academia Access across institutions is easier @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
In India explosion Hospitals adding Bioinformatics and Big Data Analytics, Databases on Infectious Diseases. Data Mining Pfizer is surveying disease data @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@ChasBountra Talking on MPACT, drug discovery the role of Academia is NOT ro replicate the excellence existing in Pharma, in Academia basic sciencec innovations to lead @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
Partnership with academia to enrich the early pipeline with new drugs Transformation on matters of science no internal expertise exist @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@JonathanEpstein @UPenn collaboration with 200 Novartis employees on site at the Medical School Clinical Trial and Manufacturing Cell-based therapies OUTSTANDING Clinicians kept the patient alive during the drug development immunetherapy @USAIC #USAIC2018 @pharma_BI @AVIVA1950
0 replies 2 retweets 2 likes
More
@SridaranNatesan major role played by New Prime Minister @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
In India major shift from publications in Journals to funding start ups, India Industry became bold, interaction with academia outside of India Sweden, Stanford, Boston – @JoslinClinic – Formulation Vaccine India Tech Transfer was a problem @USAIC #USAIC2018 @pharma_BI @AVIVA1950
@JonathanEpstein #CSO @UPenn Success of the Process wish to see results in our Life time IMPACT of innovations @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@JimGlasheen @UMMS Transfer Office has challenges of responsiveness to Faculty @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@NirmalKumarGanguly, President, @ApolloHospitals promising relationships with Academia changing mind set different organizational culture @USAIC #USAIC2018 @pharma_BI @AVIVA1950
More
@ChasBountra, Chief Scientist, Structural #Genomics Consortium @Oxford discover NOVEL #reagents given to #Academia and #Pharma @USAIC #USAIC18 @pharma_BI @AVIVA1950
More
Industry-Academic Research Partnerships Moderator: @JuanHarrison @Takeda #Industry #BigPharma #Academia STORIES @ChasBountra @Oxford @JimGlasheen @UMass @JonathanEpstein @UPenn @NirmalKumarGanguly @ApolloHospitals @SridaranNatesan @Sanofi @USAIC #USAIC18 @pharma_BI @AVIVA1950
More
@AndrewPlump, Chief Medical & Scientific Officer, @Takeda #Pharmaceuticals Government Challenges in India active is providing access and affordable #HealthCare @USAIC #USAIC18 @pharma_BI @AVIVA1950
Aviva Lev-Ari @AVIVA1950 May 7
More
12th Annual US-India BioPharma & Healthcare Summit, May 8, 2018, Marriott Cambridge @USAIC #USAIC18 @pharma_BI @AVIVA1950 https://pharmaceuticalintelligence.com/2018/01/18/12th-annual-us-india-biopharma-healthcare-summit-may-8-2018-marriott-cambridge/ … via @Pharma_BI
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Abhisar Anand
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
FrasonFrancis
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
ritusaxena
Rick Mandahl
sjwilliamspa
Srinivas Sriram
stuartlpbi
Dr. Sudipta Saha
tildabarliya
zraviv06
zs22
Leave a Reply